Sher Karki
- Molecular Biology top 2%
- Radiology, Nuclear Medicine and Imaging top 0.5%
- Cell Biology top 0.5%
- Immunology top 2%
- Oncology top 5%
- Co-authors
- Erika L.F. HolzbaurGreg A. LazarJohn R. DesjarlaisMariko TokitoClare M. WatermanHsing ChenElizabeth A HolleranWei Dang
- Topics
- Monoclonal and Polyclonal Antibodies Research (21 papers)Microtubule and mitosis dynamics (12 papers)Cellular transport and secretion (10 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Oncology
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Sher Karki
38 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Molecular Biology 2.6k
- Radiology, Nuclear Medicine and Imaging 1.7k
- Cell Biology 1.6k
- Immunology 1.0k
- Oncology 646
Countries citing papers authored by Sher Karki
This map shows the geographic impact of Sher Karki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sher Karki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sher Karki more than expected).
Fields of papers citing papers by Sher Karki
This network shows the impact of papers produced by Sher Karki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sher Karki. The network helps show where Sher Karki may publish in the future.
Co-authorship network of co-authors of Sher Karki
This figure shows the co-authorship network connecting the top 25 collaborators of Sher Karki. A scholar is included among the top collaborators of Sher Karki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sher Karki. Sher Karki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 47 | |
| 3 | 1 | |
| 4 | 45 | |
| 5 | 89 | |
| 6 | 449 | |
| 7 | 193 | |
| 8 | 187 | |
| 9 | 235 | |
| 10 | 119 | |
| 11 | Engineered antibody Fc variants with enhanced effector functionbreakdown → | 590 |
| 12 | 78 | |
| 13 | 19 | |
| 14 | 230 | |
| 15 | 32 | |
| 16 | 385 | |
| 17 | 124 | |
| 18 | 99 | |
| 19 | 57 | |
| 20 | 285 |
About Sher Karki
Sher Karki is a scholar working on Radiology, Nuclear Medicine and Imaging, Cell Biology and Genetics, having authored 38 papers that have together received 4.4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (21 papers), Microtubule and mitosis dynamics (12 papers) and Cellular transport and secretion (10 papers). The work is most often cited by research in Cell Biology (1.6k citations), Radiology, Nuclear Medicine and Imaging (1.7k citations) and Immunology (1.0k citations). Sher Karki has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Erika L.F. Holzbaur, Greg A. Lazar, John R. Desjarlais, Mariko Tokito, Clare M. Waterman, Hsing Chen, Elizabeth A Holleran, Wei Dang, Holly M. Horton and Gregory L. Moore. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.